Form 4: Hologic Executive Reports Routine Stock Transactions

Hologic's Group President, International, Jan Verstreken, reported recent stock transactions including RSU grants and tax-related share disposals.

Summary

• Jan Verstreken, Group President, International at Hologic Inc., reported multiple transactions involving the company's common stock.
• On November 7, 2025, 1,420 shares of common stock were disposed of at a price of $74.1 per share. This transaction was for the purpose of covering tax obligations related to the settlement of vested performance stock units/restricted stock units.
• On November 10, 2025, 16,823 restricted stock units (RSUs) were acquired. These RSUs are scheduled to vest in equal installments on each of the first three anniversaries of the grant date.
• On November 11, 2025, an additional 178 shares of common stock were disposed of at a price of $74.6 per share, also to satisfy tax obligations.
• Following these reported transactions, Jan Verstreken directly beneficially owns 134,235 shares of Hologic Inc. common stock.

Sentiment

Score: 7

Explanation: The filing reflects routine executive compensation and tax-related transactions. The significant RSU grant indicates continued executive alignment and commitment, which is generally positive for long-term shareholder interests.

Positives

• The acquisition of 16,823 restricted stock units aligns the executive's long-term incentives with shareholder value, demonstrating continued commitment to the company's future performance.

Negatives

• The disposal of 1,598 shares (1,420 + 178) for tax obligations, while a standard practice, results in a reduction of direct share ownership.

Future Outlook

The restricted stock units granted on November 10, 2025, are structured to vest in equal installments over the next three years, indicating a future commitment and incentive for the executive.

Industry Context

Hologic Inc. operates in the medical technology sector, specializing in women's health. The reported transactions, involving restricted stock unit grants and tax-related share disposals, are common executive compensation practices designed to align management incentives with long-term company performance within the industry.

Stakeholder Impact

• Shareholders: The RSU grant aligns the executive's interests with long-term shareholder value creation. The tax-related share disposals are routine and have a minimal impact on the overall share structure.

Next Steps

• The 16,823 restricted stock units granted on November 10, 2025, will vest in equal installments on each of the first three anniversaries of the grant date.

Key Dates

Recommendation

This Form 4 details routine insider transactions, specifically the grant of restricted stock units and subsequent tax-related share disposals. These actions are standard for executive compensation and do not indicate any significant change in the company's fundamental outlook or operational performance. Therefore, a 'hold' recommendation is appropriate as the filing itself does not provide new information warranting a change in investment thesis.

Keywords

Hologic, HOLX, Jan Verstreken, Form 4, insider trading, stock transactions, restricted stock units, RSU, executive compensation, beneficial ownership